A 2022 study from Oregon Health & Science University researchers confirmed that chronic use of cannabis may greatly impact male fertility and reproductive outcomes in nonhuman primates — but it was unclear whether the effects are permanent. Now, the OHSU research team has confirmed that discontinuing use of THC can at least partly reverse these effects, according to a new study published online today in Fertility & Sterility.
This is one of the first studies demonstrating that discontinuation of chronic THC use can partially restore negative impacts to male reproductive health in nonhuman primates.
Delta-9-tetrahydrocannabinol, or THC, is the main psychoactive ingredient in cannabis, which is one of the most commonly used drugs among men of reproductive age in the United States and worldwide. Yet there is a significant lack of safety data around THC, and users may be unaware of its potentially harmful impacts on their reproductive health. This study aimed to gain a deeper understanding of the reversibility of these impacts, which can help health care teams more effectively counsel patients — especially those interested in conceiving — on risks and recommendations for THC use.
“It’s so important that we research, understand and educate about the implications of THC on reproductive health, especially as use continues to increase among individuals of reproductive age and more states legalize cannabis,” said the study’s corresponding author Jamie Lo, M.D., M.C.R., associate professor of obstetrics and gynecology (maternal-fetal medicine), OHSU School of Medicine, and Division of Reproductive & Developmental Sciences at the Oregon National Primate Research Center, or ONPRC.
“These findings are important because we can now more confidently assure patients that by abstaining from THC for at least four months, the impacts of THC on male fertility can be partly reversed,” Lo said. “This allows for more concrete, informed recommendations for patients who are in the process of family planning or actively trying to conceive.”
The research involved a multidisciplinary team including Carol Hanna, Ph.D., director of the Assisted Reproductive Technology Core at ONPRC at OHSU, and researchers from the University of Georgia and Duke University.
In a model using nonhuman primates, researchers administered THC in progressive doses over a period of about seven months, looking specifically at changes to the tissue of the male subjects’ reproductive health organs and testes, as well as the quantity and quality of their sperm. Analyses showed that THC exposure caused a significant reduction in size of the testes and impacted male productive hormones, both which negatively impact overall fertility. In addition, THC exposure impacted the sperm, altering the regulation of genes important for nervous system development, including those linked to autism spectrum disorder.
Interestingly, after discontinuing THC exposure over a period of about four months, researchers discovered these adverse effects were partially reversed, indicating that damage from chronic THC use can be partially restored.
Though further research is needed to fully understand the biological mechanism of this reversal process, the study offers a comprehensive initial understanding of the benefit of discontinuing THC use as a part of family planning, and also provides some insight to the minimum duration of abstinence from THC needed to repair damage after chronic use. These findings can also inform providers on how to more effectively counsel patients on cannabis use prior to attempting to conceive.
“We understand that for teens and young adults, family planning might not be top of mind; however, THC even in moderate doses could impact their fertility outcomes, so this is a serious concern for us as healthcare providers,” said Jason C. Hedges, M.D., Ph.D., associate professor of urology in the OHSU School of Medicine, Division of Reproductive & Developmental Sciences at ONPRC, and the study’s lead author. “The more we can understand and define this issue, the better information we can provide to patients to be able to optimize their reproductive health.”
Looking forward, the team will continue to expand their understanding of the relationship between THC and reproductive health. Ongoing research efforts will focus on the effects of chronic THC use over long periods of time and through various modes, such as vaping, as well as investigating the impacts of THC on fetal and offspring development.
This work us supported by the American Society for Reproductive Medicine Pilot and Exploratory grant, NIH P51 OD011092, NIH R01 OD028223-01, RSDP NIH/NICHD K12 HD000849, NIH/NIDA DP1 DA056493-01, Oregon Health & Science University Medical Research Foundation Award, Oregon Health & Science University Exploratory Research SEED Grant, and the Silver Family Innovation Fund.
Research reported in this announcement was supported by the National Institute on Drug Abuse, part of the National Institutes of Health, through the under award number DP1 DA056493-01. The content presented in this release is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.
All research involving animal subjects at OHSU must be reviewed and approved by the university’s Institutional Animal Care and Use Committee (IACUC). The IACUC’s priority is to ensure the health and safety of animal research subjects. The IACUC also reviews procedures to ensure the health and safety of the people who work with the animals. The IACUC conducts a rigorous review of all animal research proposals to ensure they demonstrate scientific value; justify the use of live animals and species selected; outline steps to minimize pain and distress; document appropriate training of all staff involved; and establish the proposed study does not unnecessarily duplicate previous research. No live animal work may be conducted at OHSU without IACUC approval.